Reader Response: Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging

Neurology. 2024 Aug 13;103(3):e209343. doi: 10.1212/WNL.0000000000209343. Epub 2024 Jul 5.

Authors

Eimear Connolly¹, Antoinette O'Connor¹, Aoife Fallon¹, Seán O'Dowd¹, Seán P Kennelly¹

Affiliation

¹ (Dublin, Ireland).

PMID: 38968562
DOI: 10.1212/WNL.0000000000209343

No abstract available

Publication types

Letter

MeSH terms

Aged
Alzheimer Disease / drug therapy
Amyloid beta-Peptides
Cognitive Aging* / physiology
Humans

Substances

Amyloid beta-Peptides